filmov
tv
Introducing Signatera, a personalized, tumor-informed test
Показать описание
Natera
Рекомендации по теме
0:02:19
Introducing Signatera, a personalized, tumor-informed test
0:00:38
Introducing Signatera, a personalized, tumor-informed test
0:02:27
The Signatera Approach
0:18:43
Advances in testing: A personalized, ctDNA assay for MRD detection and surveillance
0:03:44
Angela's Story with Signatera
0:00:48
John Marshall, MD | What is Signatera?
0:02:01
Farshid Dayyani, MD | What is Signatera?
0:02:22
Signatera for immunotherapy response monitoring
0:03:00
SignaCase: A Case Review: How being informed using Signatera helped Dan through his cancer journey
0:01:43
Axel Grothey, MD | What is Signatera?
0:01:39
About Signatera and ctDNA
0:49:25
Incorporating a Personalized, Tumor-informed ctDNA Monitoring Assay in Clinical Practice
0:02:33
Arturo Loaiza-Bonilla, MD | What is Signatera?
1:00:12
Signatera - ASCO HIGHLIGHTS
0:00:55
Signatera - A New Blood Test to Detect Cancer
0:10:02
MRD detection rates with a personalized and a tumor-informed ctDNA assay in patients with stage ...
0:01:30
Gregory Botta, MD, PhD | What is Signatera?
0:02:30
Rachelle's Story
0:49:45
A ctDNA assay for remote monitoring and risk stratification
0:00:40
How Does Signatera for Immunotherapy Response Monitoring Work?
1:04:49
Signatera™ — Knowing Early Can Make a Difference
0:01:46
Natera Signatera Product Theater at SABCS 2022: The Cycle of ctDNA
0:02:54
Signatera para el control de la respuesta a la inmunoterapia
0:00:41
Natera Signatera Product Theater SABCS 2022: ctDNA Utility
0:02:19
0:00:38
0:02:27
0:18:43
0:03:44
0:00:48
0:02:01
0:02:22
0:03:00
0:01:43
0:01:39
0:49:25
0:02:33
1:00:12
0:00:55
0:10:02
0:01:30
0:02:30
0:49:45
0:00:40
1:04:49
0:01:46
0:02:54
0:00:41